283 lines
13 KiB
JSON
283 lines
13 KiB
JSON
|
{
|
|||
|
|
"OtherCopyrightsInfo": null,
|
|||
|
|
"PatentsInfo": null,
|
|||
|
|
"ProfileTags": null,
|
|||
|
|
"SoftwareCopyrightsInfo": null,
|
|||
|
|
"TrademarksInfo": null,
|
|||
|
|
"base": {
|
|||
|
|
"allows": [
|
|||
|
|
{
|
|||
|
|
"docName": "医疗器械生产企业",
|
|||
|
|
"docNo": "川食药监械生产许（2011）第0021号",
|
|||
|
|
"endDate": null
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"docName": "食品经营许可证",
|
|||
|
|
"docNo": "JY35101800028160",
|
|||
|
|
"endDate": "2019-03-20 00:00:00"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"docName": "特种设备使用许可登记",
|
|||
|
|
"docNo": "锅10川A0221(17)",
|
|||
|
|
"endDate": "2017-02-23 00:00:00"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"docName": "特种设备使用许可登记",
|
|||
|
|
"docNo": "容17川A1946(17)",
|
|||
|
|
"endDate": "2017-07-06 00:00:00"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"docName": "特种设备使用许可登记",
|
|||
|
|
"docNo": "容17川A05504(18)",
|
|||
|
|
"endDate": "2018-10-17 00:00:00"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"docName": "FZ03",
|
|||
|
|
"docNo": "川投资备【2019-510185-35-03-376357】FGQB-0439号",
|
|||
|
|
"endDate": "2019-07-26 00:00:00"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"docName": "WS02",
|
|||
|
|
"docNo": "川卫证字【2015】第201512号",
|
|||
|
|
"endDate": "2019-09-10 00:00:00"
|
|||
|
|
}
|
|||
|
|
],
|
|||
|
|
"base": {
|
|||
|
|
"authority": "简阳市市场监督管理局",
|
|||
|
|
"businessDateFrom": "2013-06-08 00:00:00",
|
|||
|
|
"businessDateTo": "2999-12-31 00:00:00",
|
|||
|
|
"businessScope": "研究、开发、生产：Ⅲ类6866医用高分子材料及制品、大容量注射剂（含血液保存液）、小容量注射剂；研究、开发、生产：Ⅲ类6845体外循环及血液处理设备；经营企业自产产品及技术的出口业务（以上所有项目中医疗器械及药品的生产、销售，按药品监督管理部门许可证核定的范围、地址及有效期内经营）；经营本企业及成员企业生产所需原辅材料、仪器仪表、机械设备、零配件及技术进出口业务（国家限定公司经营和国家禁止出口的商品及技术除外）；企业营销策划；市场营销策划；市场信息咨询与调查；企业形象策划；会务服务；会展服务；展览展示服务；从事医药、医疗科技专业领域内技术开发、技术咨询、技术服务；生物科技领域内技术开发；计算机软硬件、系统集成及应用软件的研究、开发、设计、销售；计算机网络工程、信息系统集成、信息技术咨询服务。（依法须经批准的项目，经相关部门批准后方可展开经营活动）。",
|
|||
|
|
"capital": "1290.000000万人民币",
|
|||
|
|
"companyAddress": "简阳市东溪镇奎星路28号",
|
|||
|
|
"companyCode": "512081000082736",
|
|||
|
|
"companyName": "四川南格尔生物科技有限公司",
|
|||
|
|
"companyStatus": "存续（在营、开业、在册）",
|
|||
|
|
"companyType": "其他有限责任公司",
|
|||
|
|
"creditNo": "91510185071405021T",
|
|||
|
|
"establishDate": "2013-06-08 00:00:00",
|
|||
|
|
"isOnStock": "0",
|
|||
|
|
"issueDate": "2019-09-11 00:00:00",
|
|||
|
|
"keyNo": "31c994166ce171ebb615424d10b8b15b",
|
|||
|
|
"legalPerson": "刘仁明",
|
|||
|
|
"orgCode": "071405021",
|
|||
|
|
"province": "SC",
|
|||
|
|
"revokeDate": null,
|
|||
|
|
"stockNumber": null,
|
|||
|
|
"stockType": null,
|
|||
|
|
"updatedDate": null
|
|||
|
|
},
|
|||
|
|
"branches": [],
|
|||
|
|
"changes": [
|
|||
|
|
{
|
|||
|
|
"changeAfter": "",
|
|||
|
|
"changeBefore": "研究、开发、生产：III类6866医用高分子材料及制品、大容量注射剂（含血液保存液）、小容量注射剂；研究、开发、生产：III类6845体外循环及血液处理设备；经营企业自产产品及技术的出口业务（以上所有项目中医疗器械及药品的生产、销售，按药品监督管理部门许可证核定的范围、地址及有效期内经营）；经营本企业及成员企业生产所需原辅材料、仪器仪表、机械设备、零配件及技术进出口业务（国家限定公司经营和国家禁止出口的商品及技术除外）。（依法须经批准的项目，经相关部门批准后方可开展经营活动）",
|
|||
|
|
"changeDate": "2019-09-06 00:00:00",
|
|||
|
|
"changeField": "许可经营项目变更"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"changeAfter": "成都晶富鑫企业管理中心(有限合伙)四川南格尔生物医学股份有限公司",
|
|||
|
|
"changeBefore": "四川南格尔生物医学股份有限公司",
|
|||
|
|
"changeDate": "2015-08-28 00:00:00",
|
|||
|
|
"changeField": "投资人信息变更（包括投资人、出资额、出资方式、出资日期、投资人名称等）"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"changeAfter": "860万元",
|
|||
|
|
"changeBefore": "516万元",
|
|||
|
|
"changeDate": "2015-08-28 00:00:00",
|
|||
|
|
"changeField": "注册资本变更（注册资本、注册资金、成员出资总额等变更）"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"changeAfter": "姓名:黄秀玲职务:监事|姓名:刘仁明*职务:执行董事|姓名:薛朝华职务:副总经理|姓名:杨勇职务:总经理|",
|
|||
|
|
"changeBefore": "姓名:黄秀玲职务:监事|姓名:刘仁明*职务:执行董事|姓名:杨勇职务:总经理|",
|
|||
|
|
"changeDate": "2015-08-28 00:00:00",
|
|||
|
|
"changeField": "高级管理人员备案（董事、监事、经理等）"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"changeAfter": "其他有限责任公司",
|
|||
|
|
"changeBefore": "有限责任公司(非自然人投资或控股的法人独资)",
|
|||
|
|
"changeDate": "2015-08-28 00:00:00",
|
|||
|
|
"changeField": "市场主体类型变更"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"changeAfter": "经营范围:研究、开发、生产:III类6866医用高分子材料及制品、大容量注射剂(含血液保存液)、小容量注射剂研究、开发、生产:III类6845体外循环及血液处理设备经营企业自产产品及技术的出口业务(以上所有项目中医疗器械及药品的生产、销售按药品监督管理部门许可证核定的范围、地址及有效期内经营)经营本企业及成员企业生产所需原辅材料、仪器仪表、机械设备、零配件及技术进出口业务(国家限定公司经营和国家禁止出口的商品及技术除外)。(涉及行政许可的凭许可证并在许可证有效期内经营)。",
|
|||
|
|
"changeBefore": "经营范围:研究、开发、生产:III类6866医用高分子材料及制品、大容量注射剂(含血液保存液)、小容量注射剂研究、开发、生产:III类6845体外循环及血液处理设备经营企业自产产品及技术的出口业务(以上所有项目中医疗器械及药品的生产、销售按药品监督管理部门许可证核定的范围、地址及有效期内经营)经营本企业及成员企业生产所需原辅材料、仪器仪表、机械设备、零配件及技术进出口业务(国家限定公司经营和国家禁止出口的商品及技术除外)。(涉及行政许可的凭许可证并在许可证有效期内经营)。",
|
|||
|
|
"changeDate": "2015-08-28 00:00:00",
|
|||
|
|
"changeField": "经营范围变更（含业务范围变更）"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"changeAfter": "研究、开发、生产： Ⅰ类6866医用高分子材料及制品、大容量注射剂（含血液保存液）、小容量注射剂；研究、开发、生产： Ⅱ类6845体外循环及血液处理设备；经营企业自产产品及技术的出口业务（以上所有项目中医疗器械及药品的生产、销售，按药品监督管理部门许可证核定的范围、地址及有效期内经营）；经营本企业及成员企业生产所需原辅材料、仪器仪表、机械设备、零配件及技术进出口业务（国家限定公司经营和国家禁止出口的商品及技术除外）；企业营销策划；市场营销策划；市场信息咨询与调查；企业形象策划；会务服务；会展服务；展览展示服务；从事医药、医疗科技专业领域内技术开发、技术咨询、技术服务；生物科技领域内技术开发；计算机软硬件、系统集成及应用软件的研究、开发、设计、销售；计算机网络工程、信息系统集成、信息技术咨询服务。（依法须经批准的项目，经相关部门批准后方可展开经营活动）。",
|
|||
|
|
"changeBefore": "研究、开发、生产：III类6866医用高分子材料及制品、大容量注射剂（含血液保存液）、小容量注射剂；研究、开发、生产：III类6845体外循环及血液处理设备；经营企业自产产品及技术的出口业务（以上所有项目中医疗器械及药品的生产、销售，按药品监督管理部门许可证核定的范围、地址及有效期内经营）；经营本企业及成员企业生产所需原辅材料、仪器仪表、机械设备、零配件及技术进出口业务（国家限定公司经营和国家禁止出口的商品及技术除外）。（依法须经批准的项目，经相关部门批准后方可开展经营活动）。",
|
|||
|
|
"changeDate": "2019-09-06 00:00:00",
|
|||
|
|
"changeField": "经营范围变更"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"changeAfter": "研究、开发、生产： Ⅰ类6866医用高分子材料及制品、大容量注射剂（含血液保存液）、小容量注射剂；研究、开发、生产： Ⅱ类6845体外循环及血液处理设备；经营企业自产产品及技术的出口业务（以上所有项目中医疗器械及药品的生产、销售，按药品监督管理部门许可证核定的范围、地址及有效期内经营）；经营本企业及成员企业生产所需原辅材料、仪器仪表、机械设备、零配件及技术进出口业务（国家限定公司经营和国家禁止出口的商品及技术除外）；企业营销策划；市场营销策划；市场信息咨询与调查；企业形象策划；会务服务；会展服务；展览展示服务；从事医药、医疗科技专业领域内技术开发、技术咨询、技术服务；生物科技领域内技术开发；计算机软硬件、系统集成及应用软件的研究、开发、设计、销售；计算机网络工程、信息系统集成、信息技术咨询服务。",
|
|||
|
|
"changeBefore": "",
|
|||
|
|
"changeDate": "2019-09-06 00:00:00",
|
|||
|
|
"changeField": "一般经营项目变更"
|
|||
|
|
}
|
|||
|
|
],
|
|||
|
|
"contactInfo": {
|
|||
|
|
"email": "641596206@qq.com",
|
|||
|
|
"phoneNumber": "028-27092520"
|
|||
|
|
},
|
|||
|
|
"employees": [
|
|||
|
|
{
|
|||
|
|
"employeeName": "薛朝华",
|
|||
|
|
"position": "副总经理"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "杨勇",
|
|||
|
|
"position": "总经理"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "郑亚光",
|
|||
|
|
"position": "董事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "任继萍",
|
|||
|
|
"position": "副总经理"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "凌海真",
|
|||
|
|
"position": "监事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "刘太平",
|
|||
|
|
"position": "监事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "谷加生",
|
|||
|
|
"position": "监事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "温书连",
|
|||
|
|
"position": "副总经理"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "张建和",
|
|||
|
|
"position": "董事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "罗文彬",
|
|||
|
|
"position": "监事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "凌春生",
|
|||
|
|
"position": "监事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "黄秀玲",
|
|||
|
|
"position": "监事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "滕本秀",
|
|||
|
|
"position": "董事"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"employeeName": "刘仁明",
|
|||
|
|
"position": "董事长"
|
|||
|
|
}
|
|||
|
|
],
|
|||
|
|
"exceptions": [],
|
|||
|
|
"industry": {
|
|||
|
|
"industryL1Name": "科学研究和技术服务业",
|
|||
|
|
"industryL2Name": "研究和试验发展"
|
|||
|
|
},
|
|||
|
|
"liquidation": null,
|
|||
|
|
"mPledges": [
|
|||
|
|
{
|
|||
|
|
"debtSecuredAmount": "1335万人民币",
|
|||
|
|
"publicDate": null,
|
|||
|
|
"registerDate": "2019-04-01 00:00:00",
|
|||
|
|
"registerNo": "51012019001533",
|
|||
|
|
"registerOffice": "四川省成都市简阳市工商行政管理和质量技术监督局",
|
|||
|
|
"status": "有效"
|
|||
|
|
}
|
|||
|
|
],
|
|||
|
|
"originalName": [],
|
|||
|
|
"partners": [
|
|||
|
|
{
|
|||
|
|
"capiDate": null,
|
|||
|
|
"investName": null,
|
|||
|
|
"investType": null,
|
|||
|
|
"shoudDate": null,
|
|||
|
|
"stockCapital": "516",
|
|||
|
|
"stockName": "四川南格尔生物医学股份有限公司",
|
|||
|
|
"stockPercent": "0.4000",
|
|||
|
|
"stockRealcapital": "516",
|
|||
|
|
"stockType": "企业法人"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"capiDate": null,
|
|||
|
|
"investName": null,
|
|||
|
|
"investType": null,
|
|||
|
|
"shoudDate": null,
|
|||
|
|
"stockCapital": "283.8",
|
|||
|
|
"stockName": "新的集团有限公司",
|
|||
|
|
"stockPercent": "0.2200",
|
|||
|
|
"stockRealcapital": "283.8",
|
|||
|
|
"stockType": "企业法人"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"capiDate": null,
|
|||
|
|
"investName": null,
|
|||
|
|
"investType": null,
|
|||
|
|
"shoudDate": null,
|
|||
|
|
"stockCapital": "361.20000000000005",
|
|||
|
|
"stockName": "成都晶富鑫企业管理中心（有限合伙）",
|
|||
|
|
"stockPercent": "0.2800",
|
|||
|
|
"stockRealcapital": null,
|
|||
|
|
"stockType": "合伙企业"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"capiDate": null,
|
|||
|
|
"investName": null,
|
|||
|
|
"investType": null,
|
|||
|
|
"shoudDate": null,
|
|||
|
|
"stockCapital": "129",
|
|||
|
|
"stockName": "成都同根企业管理中心（有限合伙）",
|
|||
|
|
"stockPercent": "0.1000",
|
|||
|
|
"stockRealcapital": "129",
|
|||
|
|
"stockType": "企业法人"
|
|||
|
|
}
|
|||
|
|
],
|
|||
|
|
"pledges": [],
|
|||
|
|
"punishes": [],
|
|||
|
|
"shiXinItems": [],
|
|||
|
|
"spotChecks": [],
|
|||
|
|
"taxCreditltems": [
|
|||
|
|
{
|
|||
|
|
"level": "A",
|
|||
|
|
"taxPayerName": "四川南格尔生物科技有限公司",
|
|||
|
|
"taxPayerNo": "512081071405021",
|
|||
|
|
"year": "2016"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"level": "A",
|
|||
|
|
"taxPayerName": "四川南格尔生物科技有限公司",
|
|||
|
|
"taxPayerNo": "91510185071405021T",
|
|||
|
|
"year": "2017"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"level": "A",
|
|||
|
|
"taxPayerName": "四川南格尔生物科技有限公司",
|
|||
|
|
"taxPayerNo": "91510185071405021T",
|
|||
|
|
"year": "2018"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"level": "A",
|
|||
|
|
"taxPayerName": "四川南格尔生物科技有限公司",
|
|||
|
|
"taxPayerNo": "91510185071405021T",
|
|||
|
|
"year": "2019"
|
|||
|
|
},
|
|||
|
|
{
|
|||
|
|
"level": "A",
|
|||
|
|
"taxPayerName": "四川南格尔生物科技有限公司",
|
|||
|
|
"taxPayerNo": "91510185071405021T",
|
|||
|
|
"year": "2020"
|
|||
|
|
}
|
|||
|
|
],
|
|||
|
|
"zhiXingItems": []
|
|||
|
|
}
|
|||
|
|
}
|